CD40LG and neoplasm: Platelet-rich fibrin (PRF) implants, rich in immunomodulatory factors including CD154, have shown promise as adjuvants: PRF patches inhibit tumor cells proliferation in vitro and prolong survival in glioma-bearing mice [96].